InvestorsHub Logo
Followers 65
Posts 2029
Boards Moderated 0
Alias Born 10/31/2017

Re: sentiment_stocks post# 416359

Wednesday, 11/10/2021 11:28:55 AM

Wednesday, November 10, 2021 11:28:55 AM

Post# of 701565
This is the language. It does not say when the database was locked. They say they are announcing it as of 10/5/2020. I guess they do say the data has not yet been analyzed and they do not have access at this stage, meaning on 10/5/2021. By week’s end they could have and that is a reasonable assumption to make.

I find the tenses used in the description to be confusing and ‘at this stage’ to be a curious choice of words.

BETHESDA, Md., October 5, 2020 – Northwest Biotherapeutics (OTCQB: NWBO) (“NW Bio”), a biotechnology company developing DCVax® personalized immune therapies for solid tumor cancers, today announced that the database for the Phase III trial of DCVax®-L for Gliobastoma has been locked.

With the database now locked, the independent service firms managing the Clinical Trial are arranging for the independent statisticians to have access to the unblinded raw data from the Trial. Neither the Company nor any party other than the independent statisticians will have access to any unblinded data at this stage.



I find this language to be clear and meaningful in all connotations of that word

“We are excited to be so close to the finish line now, after such a long road” commented Linda Powers, the Company’s CEO. “We are hopeful that DCVax®-L can become an important new treatment option for patients who urgently need more and better treatments for Glioblastoma brain cancer.”



For those posters who question whether I am looking and listening to what is said and when it has been said. I am. I may not have 100% recall but I am aware of what they have made officially public knowledge. I do not always understand its meaning.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NWBO News